| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/16/2007 | EP1784392A2 Pyrimidine derivatives |
| 05/16/2007 | EP1784386A2 Histone deacetylase inhibitors |
| 05/16/2007 | EP1784223A2 Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
| 05/16/2007 | EP1784216A1 S100 protein inhibitors for treating leukemia |
| 05/16/2007 | EP1784210A2 Carrier conjugates of gnrh-peptides |
| 05/16/2007 | EP1784194A1 Histone deacetylase inhibitors |
| 05/16/2007 | EP1784190A1 Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides |
| 05/16/2007 | EP1784180A2 2-amino 1h imidazo ring systems and methods |
| 05/16/2007 | EP1784175A2 Inhibitors of akt activity |
| 05/16/2007 | EP1784172A2 Cancer chemotherapy |
| 05/16/2007 | EP1534712B1 Pyrazolo[1,5-a]pyrimidine compounds as cyclin dependent kinase inhibitors |
| 05/16/2007 | EP1490407B1 Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40 |
| 05/16/2007 | EP1487981B1 Growth regulating proteins |
| 05/16/2007 | EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/16/2007 | EP1390406B1 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/16/2007 | EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 05/16/2007 | EP1355928B1 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 05/16/2007 | EP1334115B1 Phenanthridine derivatives and antitumoral medicaments containing phenanthridine |
| 05/16/2007 | EP1305285B1 N-substituted indoles useful in the treatment of diabetes |
| 05/16/2007 | EP1303307B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP1140136B1 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 05/16/2007 | EP1129190B1 Human tslp dna and polypeptides |
| 05/16/2007 | EP1085896B1 Conformationally constrained backbone cyclized somatostatin analogs |
| 05/16/2007 | CN1965082A 人源化抗体 Humanized antibodies |
| 05/16/2007 | CN1964979A Novel water-soluble prodrug |
| 05/16/2007 | CN1964963A Hydroxamates, their manufacture and use as pharmaceutical agents |
| 05/16/2007 | CN1964962A Thiophene hydroxamic acid derivatives and their use as HDAC inhibitors |
| 05/16/2007 | CN1964953A Novel 3-phenyltetrahydrocinnolin-5-ol derivative and medicinal use thereof |
| 05/16/2007 | CN1964950A Propane-1,3-dione derivative or its salt |
| 05/16/2007 | CN1964742A Combination therapy with azd2171 and 5-fu and/or cpt-11 |
| 05/16/2007 | CN1964739A Uses of anti-CTLA-4 antibodies |
| 05/16/2007 | CN1964707A Antitumor effect fortifier, antitumor agent and method of therapy for cancer |
| 05/16/2007 | CN1964630A Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus |
| 05/16/2007 | CN1962872A Ribozyme specific for cutting vessel endothelium growth factor RNA and use thereof |
| 05/16/2007 | CN1962866A Human SCARA5 gene, its coded protein and application |
| 05/16/2007 | CN1962865A Human SFRP1 gene, its coded protein and application |
| 05/16/2007 | CN1962863A PEG10-siRNA inhibiting gene expression of human PEG10 and its pharmaceutical use |
| 05/16/2007 | CN1962692A Staphylococcus aureus enterotoxin E and its preparation and uses |
| 05/16/2007 | CN1962691A Thymus tetrapeptide active isomer and its preparation method and medicinal uses |
| 05/16/2007 | CN1962689A Ciona polypeptide with resistance to angiogenesis and tumour and its preparation method |
| 05/16/2007 | CN1962684A Triterpene saponin compound, its preparing method and use thereof |
| 05/16/2007 | CN1962681A A plurality of antineoplastic sapogenin and its injection preparation method |
| 05/16/2007 | CN1962665A Extraction method of antineoplastic composition bhang flavone A from bhang |
| 05/16/2007 | CN1962656A Indomethacin 5-fluorouracil methyl ester pharmaceutical compound and its formulation and preparation method |
| 05/16/2007 | CN1962644A PI3K enzyme inhibitor-5-(3-amino-benzene) methyl nicotinate analog |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962640A Synthesis of n2 - (substituted arylmethyl) -3- (substituted phenyl) indazoles as novel anti-angiogenic agents |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961962A Amphiphilic tri-block copolymer taxol bonding medicament and synthesis method thereof |
| 05/16/2007 | CN1961954A Externally applied transdermal Chinese medicinal formulation for treating skin cancer |
| 05/16/2007 | CN1961946A Medicament for treating tumor and ulcer and preparation method thereof |
| 05/16/2007 | CN1961923A Cancer resolving ointment |
| 05/16/2007 | CN1961908A Anti-tumor pharmaceutical composition and preparation method thereof |
| 05/16/2007 | CN1961898A An antitumor compound pharmaceutical composition with barbed stullcap and preparation process thereof |
| 05/16/2007 | CN1961897A Method for verifying pomegranate rind extract |
| 05/16/2007 | CN1961896A Effective part of Chinese medicinal pseudolarix in inhibiting angiogenesis |
| 05/16/2007 | CN1961895A A novel anticancer pharmaceutical composition and preparation method thereof |
| 05/16/2007 | CN1961894A A novel compound pharmaceutical composition, preparation method and use thereof |
| 05/16/2007 | CN1961890A Use of dibutyryl cyclic adenosine monophosphate in preparation of medicament |
| 05/16/2007 | CN1961888A Lyophilized powder injection of baikal skullcap root extract and preparation method thereof |
| 05/16/2007 | CN1961885A Tetracycline derivatives and methods of use thereof |
| 05/16/2007 | CN1961880A Cancer treatment. |
| 05/16/2007 | CN1961876A Use of phthalimide derivative in preparation of medicament for resisting angiogenesis |
| 05/16/2007 | CN1961873A Application of phenhexyl isothiocyanate in preparation of medicament for treating leukemia |
| 05/16/2007 | CN1961871A An elemene formulation and preparation method thereof |
| 05/16/2007 | CN1961869A Orally disintegrating tablet of coenzyme Q10 and preparation method thereof |
| 05/16/2007 | CN1961864A Anticancer composition |
| 05/16/2007 | CN1961863A An anticancer sustained releasing agent containing mesenchyme hydrolytic reagent and cytotoxic drug |
| 05/16/2007 | CN1961862A Compound anticancer sustained releasing agent containing mesenchyme hydrolytic reagent |
| 05/16/2007 | CN1961861A An anticancer sustained releasing agent |
| 05/16/2007 | CN1961860A A solid tumor resistant tumor |
| 05/16/2007 | CN1316022C Novel chimeric TNF ligands |
| 05/16/2007 | CN1316019C Anti-CD 20 embedded antibody mutant gene and its use |
| 05/16/2007 | CN1315871C One kind of tumor relevant protein and its coding gene and application |
| 05/16/2007 | CN1315855C Molybdenum, wolfram, molybdenum and wolfram complex, method for making and use in preparing anticancer, antitumor medicament |
| 05/16/2007 | CN1315850C Axial substituted phthalocyanine compound, its preparation and application in optical kinetic treatment |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315837C Salt of gambogicacid class compound, its preparation method, and medication combination with salt as active ingredient |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315805C Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
| 05/16/2007 | CN1315536C Novel vaccine of tumor antigen, its preparation method and vaccine composition |
| 05/16/2007 | CN1315523C Auxiliary medicine for anti-tumor and its preparing method |
| 05/16/2007 | CN1315503C Compound Chinese medicine preparation for curing asthma and assisted curing tumor and AIDS and its preparing method |
| 05/16/2007 | CN1315492C Injection of Chinese medicinal agent possessing right supporting anticancer function and its preparation |
| 05/16/2007 | CN1315485C Method for preparing extracting solution of gnetum montanum which can inhibit human liver cancer cell strain |
| 05/16/2007 | CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis |
| 05/16/2007 | CN1315476C Anticarcinogen composition |
| 05/16/2007 | CN1315474C Use of ampelopsin in preparation of VEGF and bFGF inhibitor drug |
| 05/16/2007 | CN1315464C Wild aconite drip pill for treating cancer pain and its preparation method |
| 05/16/2007 | CN1315452C Pharmaceutical dosage form and method of making |
| 05/16/2007 | CA2561436A1 Medicinal composition comprising 3-alkoxy-6-allythiopyridazines for prevention or treatment of cancer of the pancreas |
| 05/15/2007 | US7217844 Useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell; reduced side effects |
| 05/15/2007 | US7217819 Immobilization of taxane; anticancer, antitumor agents |